4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
PolyPid Ltd. (PYPD) operates in the Biotechnology industry and is headquartered in Petah Tikva, Israel with about 69 employees. Its market capitalization is roughly $104 million. In the fiscal year ended 2025-12-31, PYPD reported $0M in revenue and ($34M) in net income.
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($33M) | ($28M) | ($23M) | ($39M) | — |
| Net Income | ($34M) | ($29M) | ($24M) | ($40M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($8M) | ($8M) | ($8M) | ($9M) | ($8M) | — |
| Net Income | ($8M) | ($8M) | ($8M) | ($10M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $22M | $25M | $15M | $26M | — |
| Total Liabilities | $11M | $18M | $18M | $20M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PYPD viewer.
About TickerBase · Data methodology & sources